References
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the prevention, diagnosis and management of COPD; 2019 Available from: http://goldcopd.org.
- DecramerM, CelliB, KestenS, LystigT, MehraS, TashkinDP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171–1178. doi:10.1016/s0140-6736(09)61298-819716598
- O’DonnellDE, SciurbaF, CelliB, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest. 2006;130(3):647–656. doi:10.1378/chest.130.3.64716963658
- ScottAS, BaltzanMA, DajczmanE, WolkoveN. Patient knowledge in chronic obstructive pulmonary disease: back to basics. COPD. 2011;8(5):375–379. doi:10.3109/15412555.2011.60540221936682
- WhiteR, WalkerP, RobertsS, KaliskyS, WhiteP. Bristol COPD knowledge questionnaire (BCKQ): testing what we teach patients about COPD. Chron Respir Dis. 2006;3(3):123–131. doi:10.1191/1479972306cd117oa16916006
- BootCR, van der GuldenJW, VercoulenJH, et al. Knowledge about asthma and COPD: associations with sick leave, health complaints, functional limitations, adaptation, and perceived control. Patient Educ Couns. 2005;59(1):103–109. doi:10.1016/j.pec.2004.10.00716198224
- NakkenN, JanssenDJA, van den BogaartEHA, et al. Knowledge gaps in patients with COPD and their proxies. BMC Pulm Med. 2017;17(1):136. doi:10.1186/s12890-017-0481-829084521
- DienerE, EmmonsRA, LarsenRJ, GriffinS. The satisfaction with life scale. J Pers Assess. 1985;49(1):71–75. doi:10.1207/s15327752jpa4901_1316367493
- WeinertC, BrandtPA. Measuring social support with the personal resource questionnaire. West J Nurs Res. 1987;9(4):589–602. doi:10.1177/0193945987009004113433744
- JonesPW, QuirkFH, BaveystockCM, LittlejohnsP. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
- KilSY, OhWO, KooBJ, SukMH. Relationship between depression and health-related quality of life in older Korean patients with chronic obstructive pulmonary disease. J Clin Nurs. 2010;19(9–10):1307–1314. doi:10.1111/j.1365-2702.2009.03053.x20500340
- ZigmondAS, SnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x6880820
- BjellandI, DahlAA, HaugTT, NeckelmannD. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. doi:10.1016/s0022-3999(01)00296-311832252
- ChoiJY, ChungHI, HanG. Patient outcomes according to COPD action plan adherence. J Clin Nurs. 2014;23(5–6):883–891. doi:10.1111/jocn.1229323844588
- Koehorst-Ter HuurneK, Groothuis-OudshoornCG, vanderValkPD, MovigKL, van der PalenJ, Brusse-KeizerM. Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1683–1690. doi:10.2147/copd.s16137429872286
- NgoCQ, PhanDM, VuGV, et al. Inhaler technique and adherence to inhaled medications among patients with acute exacerbation of chronic obstructive pulmonary disease in vietnam. Int J Environ Res Public Health. 2019;16(2). doi:10.3390/ijerph16020185
- HanMK, MuellerovaH, Curran-EverettD, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43–50. doi:10.1016/s2213-2600(12)70044-924321803
- WestwoodM, BourbeauJ, JonesPW, CerulliA, Capkun-NiggliG, WorthyG. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011;12:40. doi:10.1186/1465-9921-12-4021477298
- KeX, MarvelJ, YuTC, et al. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1689–1703. doi:10.2147/copd.s10896727555759
- RennardSI, VestboJ. Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(9):878–883. doi:10.1513/pats.200804-035QC19056710
- Di MarcoF, VergaM, ReggenteM, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774. doi:10.1016/j.rmed.2006.01.02616531031
- OmachiTA, KatzPP, YelinEH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med. 2009;122(8):778 e779–715. doi:10.1016/j.amjmed.2009.01.036
- JordanN, LeeTA, ValensteinM, WeissKB. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med. 2007;22(10):1447–1452. doi:10.1007/s11606-007-0328-817687614
- BosleyCM, CordenZM, ReesPJ, CochraneGM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346–2350. doi:10.1183/09031936.96.091123468947083
- KimDS, KimYS, JungKS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005;172(7):842–847. doi:10.1164/rccm.200502-259OC15976382